Patienter med eksisterende leverdysfunktion, inkl. kronisk aktiv hepatitis har øget frekvens af leverfunktionsabnormaliteter under antiretroviral kombinationsbehandling og bør monitoreres i henhold til gældende praksis.
Patients with pre-existing liver dysfunction including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.